Biomarkers to Measure Treatment Effects in Alzheimer's Disease: What Should We Look for?

Patel, S., Shah, R. J., Coleman, P., & Sabbagh, M. (2011). Potential Peripheral Biomarkers for the Diagnosis of Alzheimer's Disease. International Journal of Alzheimer＇s Disease, 2011(), 744-752. https://doi.org/10.4061/2011/572495
Mossello, E., Ballini, E., Mello, A. M., Tarantini, F., Simoni, D., Baldasseroni, S., & Marchionni, N. (2011). Biomarkers of Alzheimer's Disease: From Central Nervous System to Periphery?. International Journal of Alzheimer＇s Disease, 2011(), 345-351. https://doi.org/10.4061/2011/342980
Anoop, A., Singh, P. K., Jacob, R. S., & Maji, S. K. (2010). CSF Biomarkers for Alzheimer's Disease Diagnosis. International Journal of Alzheimer＇s Disease, 2010(), 296-307. https://doi.org/10.4061/2010/606802
Leyhe, T., Shori, T. D., Laske, C., Mielke, M. M., & Maetzler, W. (2013). Biomarkers in Alzheimer's Disease and Lewy Body Disorders with Dementia. International Journal of Alzheimer＇s Disease, 2013(), 85-86. https://doi.org/10.1155/2013/473181
Zheng, H., Fridkin, M., & Youdim, M. (2015). New Approaches to Treating Alzheimer’s Disease. Perspectives in Medicinal Chemistry, (2015), 1-8. https://doi.org/10.4137/PMC.S13210